Penetration of amphotericin B lipid formulations into pleural effusion

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 4211-4213

  Weiler, Stefan ^a   Bellmann Weiler, Rosa ^a   Joannidis, Michael ^a   Bellmann, Romuald ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PENETRATION; FEMALE; HUMAN; MALE; MYCOSIS; PLEURA EFFUSION; PRIORITY JOURNAL;

ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CRITICAL ILLNESS; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PLEURAL EFFUSION;

EID: 35848930404     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01087-07     Document Type: Article

References (23)

1. Bellmann, R., P. Egger, and C. J. Wiedermann. 2003. Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence. Clin. Infect. Dis. 36:1500-1501.
2. Byl, B., F. Jacobs, P. Wallemacq, C. Rossi, P. de Francquen, M. Cappello, T. Leal, and J. P. Thys. 2003. Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion. Antimicrob. Agents Chemother. 47:2015-2017.
3. Egger, P., R. Bellmann, and C. J. Wiedermann. 2001. Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography. J. Chromatogr. B 760:307-313.
4. Espinel-Ingroff, A., K. Boyle, and D. J. Sheehan. 2001. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 150:101-115.
5. Failla, P. J., F. P. Cerise, G. H. Karam, and W. R. Summer. 1995. Blastomycosis: pulmonary and pleural manifestations. South. Med. J. 88:405-410.
6. Fukuchi, M., Y. Mizushima, T. Hori, and M. Kobayashi. 1998. Cryptococcal pleural effusion in a patient with chronic renal failure receiving long-term corticosteroid therapy for rheumatoid arthritis. Intern. Med. 37:534-537.
7. Groll, A. H., C. A. Lyman, V. Petraitis, R. Petraitiene, D. Armstrong, D. Mickiene, R. M. Alfaro, R. L. Schaufele, T. Sein, J. Bacher, and T. J. Walsh. 2006. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations. Antimicrob. Agents Chemother. 50:3418-3423.
8. Jacobs, F., M. Marchai, P. de Francquen, J. P. Kains, D. Gangji, and J. P. Thys. 1990. Penetration of ciprofloxacin into human pleural fluid. Antimicrob. Agents Chemother. 34:934-936.
9. Ko, S. C., K. Y. Chen, P. R. Hsueh, K. T. Luh, and P. C. Yang. 2000. Fungal empyema thoracis: an emerging clinical entity. Chest 117:1672-1678.
10. Light, R. W. 2002. Clinical practice. Pleural effusion. N. Engl. J. Med. 346:1971-1977.
11. Marshall, B. C., J. K. Cox, Jr., K. C. Carroll, and R. E. Morrison. 1990. Histoplasmosis as a cause of pleural effusion in the acquired immunodeficiency syndrome. Am. J. Med. Sci. 300:98-101.
12. Morgenroth, A., H. P. Pfeuffer, R. Seelmann, and H. Schweisfurth. 1991. Pleural penetration of ciprofloxacin in patients with empyema thoracis. Chest 100:406-409.
13. Newman, T. G., A. Soni, S. Acaron, and C. T. Huang. 1987. Pleural cryptococcosis in the acquired immune deficiency syndrome. Chest 91:459-461.
14. Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb for the NIAID Mycoses Study Group and the Candidemia Study Group. 1995. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 39:40-44.
15. Stern, J. B., P. Girard, and R. Caliandro. 2004. Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis. Antimicrob. Agents Chemother. 48:1065.
16. Teixcira, L. R., S. A. Sasse, M. A. Villarino, T. Nguyen, M. E. Mulligan, and R. W. Light. 2000. Antibiotic levels in empyemic pleural fluid. Chest 117: 1734-1739.
17. Thys, J. P., P. Vanderhoeft, A. Herchuelz, P. Bergmann, and E. Yourassowsky. 1988. Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas. Chest 93:530-532.
18. van der Voort, P. H., E. C. Boerma, and J. P. Yska. 2007. Serum and intraperitoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis. J. Antimicrob. Chemother. 59:952-956.
19. Vogelsinger, H., S. Weiler, A. Djanani, J. Kountchev, R. Bellmann-Weiler, C. J. Wiedermann, and R. Bellmann. 2006. Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion. J. Antimicrob. Chemother. 57:1153-1160.
20. Wong, C. M., K. H. Lim, and C. K. Liam. 1999. Massive pleural effusions in cryptococcal meningitis. Postgrad. Med. J. 75:297-298.
21. Wong-Beringer, A., R. A. Jacobs, and B. J. Guglielmo. 1998. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin. Infect. Dis. 27:603-618.
22. Yamada, H., T. Iwanaga, H. Nakanishi, M. Yamaguchi, and K. Iida. 1985. Penetration and clearance of cefoperazone and moxalactam in pleural fluid. Antimicrob. Agents Chemother. 27:93-95.
23. Yew, W. W., J. Lee, C. Y. Chan, S. W. Cheung, P. C. Wong, and S. Y. Kwan. 1991. Ofloxacin penetration into tuberculous pleural effusion. Antimicrob. Agents Chemother. 35:2159-2160.